About the Startup
Vienna-based biotech spin-off developing a novel transcriptomic-dynamics platform to identify and develop first-in-class drug candidates, primarily focused on oncology with plans to expand into autoimmune and inflammatory diseases.
Frequently Asked Questions
What type of funding round did Quantro Therapeutics raise?
Quantro Therapeutics raised a unspecified round.
When did Quantro Therapeutics raise its unspecified?
Quantro Therapeutics raised its unspecified on 2025-11-27.
Who invested in Quantro Therapeutics's unspecified?
The investors in Quantro Therapeutics's unspecified are: Boehringer Ingelheim Venture Fund (BIVF), Evotec.
What type of investment was Quantro Therapeutics's unspecified?
Quantro Therapeutics's unspecified was a equity investment.